Key points are not available for this paper at this time.
Our results emphasize the need of early and complete revascularization in STEMI and non-STEMI, respectively, and of further investigation to inform customized cardioprotective pharmacotherapies in patients with concomitant risk factors and comorbidities, given their risk of developing impaired LVEF.
Eggers et al. (Mon,) studied this question.